IP Library Granted Patent US 8,383,156
Granted Patent B2
US 8,383,156 · App. 11/741,997 · Granted Feb 26, 2013

Coating for a medical device having an anti-thrombotic conjugate

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,383,156
App. No.
11/741,997
Granted
Feb 26, 2013
Kind
B2
Abstract

Methods for making comb-type antithrombotic conjugate wherein substantially all side chains of water soluble poly(vinyl alcohol) (PVA) are extended by ring-opening polymerization to form a copolymer wherein substantially all terminals are conjugated to an antithrombotic molecule. In addition, a method is provided for applying a coating comprising a comb-type anti-thrombotic conjugate to at least a portion of an implantable device to prevent or reduce the formation of thrombosis on the surface of the device. A first or sub-layer of the coating is prepared by mixing a polymeric material and a biologically active agent with a solvent, thereby forming a homogeneous solution. A second or outer layer comprising a comb-type anti-thrombotic conjugate may be applied over the inner drug-containing layers using, for example, a dip coating or spray coating process. Alternatively the comb-type antithrombotic conjugate may be used as a matrix material to encapsulate a pharmaceutical agent to form microspheres or nanospheres before depositing the microspheres or nanospheres onto a medical device.

Claims (2)

1. An amphiphilic material for implantable medical devices comprising a biocompatible, bioabsorbable, hydrophobic polymer backbone having hydrophilic, antithrombotic end groups configured as an amphiphilic structure, the material having the following structure:

wherein n is an integer of 2-1000; and m is an integer of 100 to 5000; LA is repeating unit of lactic acid; SA is succinic acid; Hp is unmodified heparin conjugated to the material, the lactic acid, the succinic acid and the unmodified heparin form an integral part of the amphiphilic material the overall structure being comb-type in shape.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2025
From: CARDINAL HEALTH SWITZERLAND 515 GMBH; CARDINAL HEALTH 529, LLC; CORDIS CORPORATION; FLEXIBLE STENTING SOLUTIONS, INC
To: CORDIS US CORP
Reel/Frame 072987/0675 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2017
From: CORDIS CORPORATION
To: CARDINAL HEALTH SWITZERLAND 515 GMBH
Reel/Frame 042126/0259 →